Cannabis Law Report

JUNE 23, 2021

Valcon Medical A/S Announces Receipt of EU GMP Certification and Start of Commercial Production for Pharmaceutical-Grade Cannabis Concentrates, Intermediary Products, and Medical Formulations (PRNewsfoto/Valcon Medical A/S). and BÜCHI Labortechnik AG, both leaders in cannabis production and processing services. About Valcon Medical.

Pharmaceutical 86

Pharmaceutical Concentrates Extraction Medicine 86

Cannabis Law Report

MAY 29, 2021

The authorization procedure for the extraction of active ingredients and the production of cannabis extracts was published by the Ministry of Health after an explicit request from the M5S. The Ministry of Health, at our request, has made public the authorization procedure for the manufacture of cannabis extracts on its portal .

Extraction 78

Extraction Agriculture Cultivation Pharmaceutical 78

Cannabis Law Report

JANUARY 18, 2023

UK-based Celadon Pharmaceuticals PLC received the green light to produce high-THC medicinal cannabis in its Midlands facility, reported London South East. The move follows seven harvests and extractions in 2022 and the […]

Pharmaceutical 52

Pharmaceutical Medicine THC Extraction 52

Cannabis Law Report

DECEMBER 23, 2021

DUBLIN–(BUSINESS WIRE)– “The Pharmaceutical Cannabis Report: 2nd Edition” report has been added to ResearchAndMarkets.com’s offering. In both Europe and the United States, the sales of unapproved cannabis products such as smokable flower and full spectrum oils dwarf those of approved pharmaceuticals.

Pharmaceutical 96

Pharmaceutical Clinical Trials Research and Development Cannabinoids 96

Cannabis Law Report

JUNE 23, 2020

Health officials in the Czech Republic have allowed a local extraction facility to export full-spectrum hemp-derived cannabis extract to a Spanish pharmaceutical ingredient manufacturer. Prague-based … Read More.

Extraction 98

Extraction Hemp Pharmaceutical Cannabis 98

Cannabis Law Report

JUNE 5, 2019

Press Release: Thailand Government Pharmaceutical Organization. The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. 30 May 2019.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

Cannabis Life Network

FEBRUARY 11, 2021

A patent for CO2 extraction of cannabis has been acquired by Canopy Growth Corporation (TSX:WEED), but will small cannabis companies become potential targets? (1) 1) We were curious if there is any weight to Canopy’s new infringement allegations against GW Pharmaceuticals (GWPH). He has […].

Extraction 113

Extraction Pharmaceutical Cannabis Legalization 113

Cannabis Law Report

JUNE 1, 2022

Pharmadrug GmbH has been active worldwide for almost 40 years as a manufacturer and wholesaler of medicinal products and active pharmaceutical ingredients. Our team in Europe is excited to join forces with new colleagues from Pharmadrug GmbH, with their valuable expertise in the German pharmaceutical market.”

Pharmaceutical 52

Pharmaceutical Medicine Extraction Cannabinoids 52

Cannabis Law Report

NOVEMBER 3, 2021

This is a strategic opportunity for us to reach the widest audience of customers possible while being the first and, at the moment, the only company with a permit to market cannabis extracts for inhalation in Germany specifically and in Europe in general.

Extraction 52

Extraction Pharmaceutical Patients Treatment 52

Project CBD

JULY 31, 2018

In June 2018, the Food and Drug Administration ( FDA ) gave its blessing to “Epidiolex,” a purfied CBD pharmaceutical, for treating severe pediatric epilepsy. Six months later, Congress passed the Farm Bill, which legalized the cultivation of industrial hemp for many uses, including the production of biomass for CBD oil extraction.

Oil 237

Oil CBD Epilepsy Pharmaceutical 237

Cannabis Law Report

JANUARY 13, 2020

Hemp Synergistics, a hemp extraction laboratory producing THC-free custom CBD formulations recently announced it received $1.5 million in seed funding to launch a high-tech laboratory. The lab has been designed to resolve the problem of inconsistent THC levels in a range of cannabinoid-based consumer products, the company told Benzinga.

Extraction 66

Extraction Hemp Environment Pharmaceutical 66

Cannabis Law Report

JANUARY 19, 2022

(ASX: LGP) (“LGP”), a vertically integrated cannabis manufacturer, that AMP has been appointed as marketer and distributor of LGP medical cannabis extracts to pharmacies and clinics in Germany , including exclusive distributor of LGP’s 20:5 LGP Classic and 10:10 LGP Classic extract oils. ” Ms.

Extraction 52

Extraction Oil Research and Development Medicine 52

Cannabis Law Report

NOVEMBER 12, 2021

Ethypharm has signed an exclusive license agreement with Clever Leaves for the distribution of medical cannabis extracts in Germany, the most important European market for medical cannabis. Clever Leaves will manufacture and supply EU GMP certified medical cannabis extracts sourced from their facilities in Colombia and Portugal.

Extraction 52

Extraction Chronic Pain Pharmaceutical THC 52

Cannabis Law Report

JANUARY 11, 2022

Flora’s cultivation and extraction division, Cosechemos, completed construction of a 10,500 ft 2 state-of-the-art post-harvest and extraction facility with annual capacity of 15,000 L of distillate. At this time, the team is continuing commercial CBD extraction.

Extraction 52

Extraction Wellness and Beauty Cultivation Events 52

Project CBD

JULY 31, 2018

With Congress seemingly poised to legalize the cultivation of industrial hemp for many uses, including the production of biomass for CBD oil extraction, many questions remain unanswered. How will the DEA reschedule CBD now that Epidiolex has been approved as a pharmaceutical CBD isolate?

Hemp 203

Hemp CBD DEA Pharmaceutical 203

Project CBD

OCTOBER 26, 2023

United Kingdom-based GW Pharmaceuticals has produced the world’s first approved cannabis-based medicines for the UK, US, and European markets, Sativex® and Epidiolex®. GW Pharmaceuticals’ research on glioblastoma multiforme (GBM) is important and promising. Note: In May 2021, GW Pharmaceuticals was acquired by Jazz Pharmaceuticals.]

Research and Development 343

Research and Development Cannabinoids Terpenes Pharmaceutical 343

Cannabis Law Report

FEBRUARY 23, 2020

Clever Leaves , a leading multi-national operator (MNO) and licensed producer of pharmaceutical-grade medical cannabis and hemp extracts, has now launched its new direct-to-business sales platform which offers pharmaceutical-grade cannabis extracts and finished products fit for a broad range of industries.

Extraction 59

Extraction Supply Chain Business Pharmaceutical 59

Cannabis Law Report

JULY 21, 2019

FWB: 8K51)(OTC: WLDCF) (the “Company” or “ ICC ” or “ International Cannabis”) is pleased to announce that the Company has entered into an exclusive supply and commercial rights agreement (the “Agreement”) with licensed New Zealand medical cannabis company, NUBU Pharmaceuticals (“NUBU”). (CSE: WRLD.U)(FWB:

Pharmaceutical 40

Pharmaceutical THC CBD Supply Chain 40

Cannabis Law Report

JULY 19, 2019

FWB: 8K51)(OTC: WLDCF) (the “Company” or “ ICC ” or “ International Cannabis”) is pleased to announce that the Company has entered into an exclusive supply and commercial rights agreement (the “Agreement”) with licensed New Zealand medical cannabis company, NUBU Pharmaceuticals (“NUBU”). (CSE: WRLD.U)(FWB:

Pharmaceutical 40

Pharmaceutical THC CBD Supply Chain 40

Cannabis Law Report

SEPTEMBER 3, 2019

Thailand has removed cannabis and hemp extracts from its narcotics list, officials said on Monday, the latest effort to promote the development of marijuana products for medical purposes. “We are working towards cannabidiol (CBD) extraction, that’s our short term goal,” Shah told Reuters.

Extraction 45

Extraction Hemp Research and Development Media 45

Cannabis Law Report

OCTOBER 26, 2019

The US subsidiary of GW Pharmaceuticals, behind the only FDA-approved cannabis extract-based medicine, is lobbying in all 50 states. GW is the world’s oldest and largest pharmaceutical company solely focused on producing medicines derived from cannabis plants, which it grows in Britain. By Nikitha Sattiraju.

Pharmaceutical 45

Pharmaceutical Research and Development Banking Therapy 45

Cannabis Law Report

JULY 2, 2021

Dr. Rungpetch Sakulbumrungsilp Dean of the Faculty of Pharmaceutical Sciences, Chulalongkorn University. Dr. Rungpetch Sakulbumrungsilp, Dean of the Faculty of Pharmaceutical Sciences, Chulalongkorn University, unlike the present in which many facets and aspects of cannabis are being studied in addition to the work of Chula C.A.N.S.,

Research and Development 105

Research and Development Pharmaceutical Extraction Seed-To-Sale 105

Cannabis Law Report

SEPTEMBER 14, 2021

Join Us in Advancing Cannabis Science to Elevate the Industry , by Pelin Thorogood, Co-founder and Executive Chair of Radicle Science, and Nicole Brown, Chief Innovation Officer of Open Book Extracts. About Open Book Extracts. About Radicle Science. To learn more, please visit www.radiclescience.com and follow their LinkedIn page.

Extraction 52

Extraction Research and Development Clinical Trials CBD 52

Cannabis Law Report

APRIL 2, 2023

Biomind Labs” or the “Company”) (NEO: BMND) (OTC: BMNDF) (FSE: 3XI), a leading biotech company focused on developing the next generation of pharmaceuticals to treat patients suffering from neurological disorders by targeting the drivers of disease, is pleased to announce that it has successfully […]

Extraction 52

Extraction Pharmaceutical Patients Business 52

Cannabis Law Report

SEPTEMBER 8, 2021

Flora will now have the ability to quickly and efficiently reference and manage information at its cultivation and extraction facility, collect and analyze data, derive insights to find cost efficiencies, and ensure accuracy. MIAMI & TORONTO–(BUSINESS WIRE)–Flora Growth Corp. For more information, please visit www.trutrace.co.

Supply Chain 95

Supply Chain Pharmaceutical Seed-To-Sale Events 95

Green Relief

MARCH 25, 2018

An extremely interesting study (Overcoming the Bell-Shaped Dose-Response of Cannabidiol by using Cannabis Extract Enriched in Cannabidiol) was just published out of the Lautenberg Center for General and Tumor Immunology in Jerusalem. Materials Used: Plants, Animals, and Extracts. The purified CBD was acquired from THC Pharm.

Extraction 41

Extraction CBD Cannabinoids Strains 41

Cannabis Law Report

SEPTEMBER 1, 2020

TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative … Read More. MediPharm Labs Corp.

Pharmaceutical 98

Pharmaceutical Extraction Cannabis Law 98

Cannabis Law Report

AUGUST 18, 2021

Seed confirmed on Tuesday that Eurox had successfully launched its own “unique” brand of ‘made in Germany’ full-spectrum medical cannabis extracts, representing a milestone for the company, with products now available for German pharmacies to order. Seed has an 8.85% shareholding in Eurox.

Extraction 105

Extraction Pharmaceutical THC Patients 105

Cannabis Law Report

SEPTEMBER 7, 2022

The acquisition by Ramm provides access to HemPoland’s distribution network, recognized premium brands, hemp oil extraction technologies, and an additional synergistic foothold into the European market following the acquisition of Sicily-based Canapar Corp. About RAMM Pharma Corp. g, Poland (60 kilometres east of Gda?sk), HemPoland S.p.a.

Hemp 59

Hemp Pharmaceutical Extraction Cannabinoids 59

Cannabis Law Report

NOVEMBER 23, 2021

SOMAÍ Pharmaceuticals Unipessoal LDA, or SOMAÍ, recently received an “innovative products” grant of 2.7 Provided by the Portugal 2020 committee, the grant will help Somaí continue its mission of developing high-quality and efficacious cannabis pharmaceuticals for the European market. million euros ($3.07

Pharmaceutical 52

Pharmaceutical Research and Development Cannabinoids Extraction 52

Cannabis Law Report

AUGUST 1, 2021

In May this year the Greek Parliament passed the draft production, extraction and distribution of final products of pharmaceutical cannabis of the species Cannabis Sativa containing over 0.2% Tetrahydrocannabinol (THC).

Sativa 105

Sativa Pharmaceutical Extraction Cultivation 105

Otherside Farms

MAY 1, 2023

As the cannabis industry continues to grow, the need for high-quality extraction methods becomes more important than ever. So, if you’re looking to take your cannabis business to the next level, it’s time to hop on the CO2 extraction train. What exactly is CO2 Extraction?

Extraction 52

Extraction Terpenes Oil Cannabinoids 52

Project CBD

JULY 28, 2023

He has guided clients on license applications, facility design and build out, equipment installation and optimization, and plant oil extraction for cannabis and hemp processing facilities. with unknown pharmacological and safety profiles.”

THC 212

THC Cannabinoids Hemp Research and Development 212

Cannabis Chronicles

APRIL 2, 2019

People have been drawn to the extract because of its supposed calming effects. The FDA has approved a pharmaceutical version of CBD to treat rare seizure disorders. NEW YORK — U.S. CBD comes from marijuana or hemp plants but does not cause a high.

CBD 113

CBD Food Pharmaceutical Collective 113

Veriheal

AUGUST 9, 2023

This new research has increased our hopes for an alternate CBD source, which may increase the availability of CBD-based products, reduce purchase costs, and guarantee THC-free extracts. Even more, CBD is the first FDA-approved pharmaceutical drug for two rare forms of epileptic seizures in kids.

CBD 96

CBD Cannabinoids THC Extraction 96

Cannabis Law Report

JUNE 4, 2020

Million Square Feet of Greenhouses, Clever Leaves is One of the Largest Cannabis Cultivation and Extraction Companies in the World- CORRECTION…by … Read More. -With More than 1.9

Pharmaceutical 59

Pharmaceutical Extraction Cultivation Business 59

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. Zambon is a multinational pharmaceutical company that focuses on innovation and development with the aim to improve patients’ lives. The market for medical cannabis in Germany.

Access 105

Access Research and Development Pharmaceutical Therapy 105